XYNERGY HOLDINGS INCORPORATED (OTC: XYNH)
"Up 440.00% on Monday"

Detailed Quote: http://www.otcpicks.com/quotes/XYNH.php

Xynergy Holdings, Inc. is committed to meeting the world’s growing energy needs while also promoting environmentally conscious business practices and sustainability. Their focus is on promoting global commerce within the realm of a global economy.

XYNH News:

June 26 - Xynergy Holdings Announces Breakthrough Results for Hydro X Assist™ Technology

Unique Installation and Component Coupling Produces Fuel Efficiency Increase of 87.5% in '08 Toyota Yaris, to 60 MPG

Xynergy Holdings, Inc. (OTC: XYNH) announced that results achieved during its three month Research and Development project involving the company’s Hydro X Assist™ Technology and a 2008 Toyota Yaris were impressive, and have surpassed the company’s expectations in terms of gaining fuel efficiency increases.

The Yaris has a factory MPG listing of 29/36. With the installation of the Hydro X Assist kit in the test vehicle, the tests yielded an amazing 60 average MPG using top off methodology.

“Needless to say, in light of what appears to be another upward tick in oil prices, our results signify a milestone for hydro assist technologies and consumer vehicles; consumers will have the ability to improve their fuel efficiency even in new vehicles, and more particularly in vehicles that already are considered to be fuel efficient,” says CEO J. Carlos Ley. “The consumer will always look to save money on fuel, and this test proves that it can be done.”

The Hydro X Assist™ Technology and installation process is extremely effective, using distilled water combined with electrolysis to produce hydrogen using only 12 volts. Using water alone would require 1000 volts. The Hydro X Assist technology creates a greater volume of hydrogen, and does so much more quickly.

NEAH POWER SYSTEMS (OTCBB: NPWS)
"Up 42.99% on Monday"

Detailed Quote: http://www.otcpicks.com/quotes/NPWS.php

NEAH Power Systems, Inc. (NPWS) is developing long-lasting, efficient and safe power solutions for the military and for portable electronic devices. NEAH uses a unique, patented, silicon-based design for its micro fuel cells that enable higher power densities, lower cost and compact form-factors. The company's micro fuel cell system can run in aerobic and anaerobic modes.

NPWS News:

June 25 - NEAH Successfully Tests Anaerobic Direct Methanol Fuel Cell Prototype

NEAH Power Systems, Inc. (OTCBB: NPWS), the Company developing fuel cells for the military and portable electronic devices, announced today it has successfully demonstrated a new type of low cost, high reliability and power, liquid electrolyte based direct methanol fuel cell that does not require air to operate. This is the first major innovation in fuel cell technology in over 20 years, where a repeatable, reliable non-PEM based system has been successfully introduced and demonstrated in sustained operation.

The prototype was self contained and sized to generate 8W of gross power, fuel cartridges were replaced multiple times and repeatable performance demonstrated. A video of the technology, markets that NEAH serves, and demonstration of the technology will be posted on YouTube, as well as on the company's website, www.neahpower.com, and NEAH has invited any interested parties to visit the company to see the system in operation.

"We are thankful to the Office of Naval Research for funding significant portions of this research. This technology is singular in that it can operate in places where air isn't available," Dr. Chris D'Couto, NEAH's President and Chief Executive Officer, noted. "This system can service many specialized markets, such as underwater and surface water manned and unmanned vehicles, as well as numerous aerospace applications, and will be the building block for fuel cell solutions for Hobie Cat and other key customers." NEAH fuel cells operate in both an aerobic and anaerobic manner. "Our micro fuel cells may eventually replace batteries for most uses," D'Couto said, "meaning that cost-efficient and 'green' technology is at hand to not only preserve the environment, but to provide nearly perpetual power to the military, manufacturers of almost any product that require an energy source, and to the millions of consumers who require energy on the go."

SYMPOWERCO CORPORATION (OTC: SYMW)
"Up 150.00% on Monday"

Detailed Quote: http://www.otcpicks.com/quotes/SYMW.php

SymPowerco Corporation develops advanced fuel cell and power delivery systems for the rapidly growing personal transportation and portable power system markets being created by today's energy and environmental challenges.

SYMW News:

May 27 - SymPowerco Receives Grant Approval for Fuel Cell Project

SymPowerco Corporation (OTC: SYMW) CEO John Davenport announced that the company's majority-owned subsidiary, Polygenic Power Systems ("PPS"), has been notified that its application for grant funding from a major North American Government Agency has been approved. The funding, when received by PPS and its partners, will support SymPowerco's Flowing Electrolyte Direct Methanol Fuel Cell (FEDMFC) advanced development program.

SymPowerco's extensive grant application included detailed development plans for the FEDMFC project including engineering objectives, scalability testing as well as detailed manufacturing and marketing plans. As a result of the funding approval, SymPowerco intends to complete and implement its development plans with its project partners, Hybrid Energy Technologies, Inc. and Carleton University in Ontario, Canada. Development activities under this project are expected to start in late summer or early fall of 2009.

Stated SymPowerco President and CEO, John Davenport, "We at SymPowerco are very pleased that our grant application has been approved. Like all such applications, our application was subject to rigorous academic and industrial peer reviews before final acceptance. We have successfully completed that process and we can now move forward with our plans. We believe that our Flowing Electrolyte Direct Methanol Fuel Cell will be a strong candidate for a wide variety of Hybrid Power System and Fuel Cell markets."

SAFEGUARD SECURITY HOLDINGS INCORPORATED (OTC: SSHS)
"Up 105.33% on Monday"

Detailed Quote: http://www.otcpicks.com/quotes/SSHS.php

Through its operating subsidiaries and divisions, Safeguard Security Holdings is a single source security solutions provider, integrating technical and physical security assets. The company is organized along three distinct lines of business: Technical Systems, Security Personnel and Security Outsourcing Solutions. Its operations are directed from its offices in Dallas, Texas.

SSHS News:

June 10 - Safeguard Board Appoints New Vice President for Systems Group

Safeguard Security Holdings, Inc. (OTC: SSHS), a provider of corporate and industrial security systems and personnel, announces today that the Board of Directors have appointed Shelly Anderson, Vice President, Operations, for its SYSTEMSgroup business unit and all operating divisions.

Ms. Anderson is a retired executive of TXU with 15 years of service to the massive power utility company. During her tenure, she was appointed as Corporate Security Manager in 2005, and held that position for over three years prior to her retirement. Ms. Anderson worked with SYSTEMSgroup as her security vendor during that period and now assumes her new management role as the vendor (SYSTEMSgroup) serving her previous employer. Ms Anderson will spearhead the operations of all divisions of SYSTEMSgroup, including SYSTEMSgroup Security Resources, SYSTEMSgroup Protective Services, SGI Protective Services and its investigations and patrol divisions.

R. Michael Lagow, CEO of Safeguard, the parent company to SYSTEMSgroup, stated, “We are fortunate to have a long term relationship with Shelly and due to her experience and knowledge of TXU, it only made sense for her to assume the role as our new Vice President of Operations, serving our entire client base as well as one of our largest power utility clients in Texas. Shelly is a exceptional talent and we are delighted to have her join our team!”

DECODE GENETICS INCORPORATED (NASDAQ: DCGN)
"Up 33.72% on Monday"

Detailed Quote: http://www.otcpicks.com/quotes/DCGN.php

deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of diagnostics and drugs for common diseases. deCODE is a global leader in gene discovery — our population approach and resources have enabled us to isolate key genes contributing to major public health challenges from cardiovascular disease to cancer, genes that are providing us with drug targets rooted in the basic biology of disease. Through its CLIA-registered laboratory, deCODE is offering a growing range of DNA-based tests for gauging risk and empowering prevention of common diseases, including deCODE T2™ for type 2 diabetes; deCODE AF™ for atrial fibrillation and stroke; deCODE MI™ for heart attack; deCODE ProCa™ for prostate cancer; deCODE Glaucoma™ for a major type of glaucoma. deCODE is delivering on the promise of the new genetics.

DCGN News:

June 29 - deCODE Discovers a Gene Linked to Risk of Kidney Stones and Osteoporosis

Findings Offer Promising Target for Drugs to Better Regulate Calcium Metabolism, Are Integrated Into deCODEme™

A discovery by scientists at deCODE Genetics (Nasdaq: DCGN) and academic colleagues from Iceland, the Netherlands and Denmark has pointed to a common biological mechanism contributing to both kidney stones and decreased bone mineral density (BMD). About 60% of the population carry two copies of a single-letter variation in the human genome (SNP) on chromosome 21, putting them at roughly 65% greater likelihood of developing kidney stones than those who carry no copies. This single variant may thus account for more than a quarter of the incidence of kidney stones, and in women carriers it is also associated with decreased BMD at the hip and spine. The study, which involved the analysis of the genomes of some 50,000 patients and controls, is published in the online edition of Nature Genetics at http://www.nature.com/ng and will appear in upcoming print edition of the journal.

The SNP is in the gene encoding claudin 14 (CLDN14), a protein expressed in the kidney and one of a family of membrane proteins that regulate the passage of ions and small solutes between cells. As calcium is a key component both of most kidney stones and of bone, the deCODE team examined the relationship between CLDN14 and the metabolism of calcium. The results suggest that the SNP may be contributing to increased calcium excretion in urine, a major risk factor for kidney stones and also a sign of bone loss.

"This is an exciting finding because it uncovers a highly plausible common biological mechanism leading to two diseases. This offers a potentially attractive new pathway for drug discovery, and the next task is to build on our understanding of how this SNP increases risk of these diseases and how this pathway could be targeted therapeutically to address this risk. As ever, deCODEme subscribers will see this new variant in their profiles, and we look forward building on this discovery," said Kari Stefansson, CEO of deCODE.

ABOUT KIDNEY STONES

Kidney stones are small crystals formed of dissolved minerals, mainly calcium, that form in the kidneys. Smaller stones can simply be passed through urination, though larger ones can block the urinary tract, causing considerable pain and bleeding. Kidney stones affect some 5% of women and 10% of men in the industrialized world. Larger stones can be detected with ultrasound screening and broken up to facilitate passage, though the recurrence rate is high.

deCODE would like to thank all those who participated in this study, as well as the collaborating clinicians and scientists from the Landspitali University Hospital in Reykjavik, Iceland; Radboud University Nijmegen Medical Centre in Nijmegen, Netherlands; Nordic Bioscience A/S in Herlev, Denmark; and the Center for Clinical and Basic Research A/S in Ballerup, Denmark.

NEXMED INCORPORATED (NASDAQ: NEXM)
"Up 28.54% on Monday"

Detailed Quote: http://www.otcpicks.com/quotes/NEXM.php

NexMed’s pipeline includes its innovative topical onychomycosis treatment, which is licensed to Novartis for global development, a late stage alprostadil treatment for erectile dysfunction, a Phase 2 treatment for female sexual arousal disorder, and an early stage treatment for psoriasis.

NEXM News:

June 19 - TheFortuneFinancial.com Free Market Research on NEXM, SPPI, URBN and ASML

The Following Is an Investment Opinion Being Issued by TheFortuneFinancial.com.

On June 19, TheFortuneFinancial.com asked some of the top analysts worldwide to give their updated feedback regarding the current market activity and position on NexMed Inc. (Nasdaq: NEXM), Spectrum Pharmaceuticals Inc. (Nasdaq: SPPI), Urban Outfitters Inc. (Nasdaq: URBN) and ASML Holding NV (Nasdaq: ASML).

To have free access to these analyst opinions, sign up now to www.thefortunefinancial.com by clicking the link below.

http://www.thefortunefinancial.com/index.php?id=78

All analyst reviews will be posted for free under "today's articles" within 24 hours they are advertised online.

Each interview will vary and may include, but will not be limited to the following:

– An Unbiased View of the Company
– Short–term Target Prices
– Long–term Resistance and Support Levels
– Analyst Opinions
– Sector Review
– Competition Overview